Khalid Shah

Company: Brigham & Women's Hospital at Harvard Medical School

Job title: Vice Chairman

Seminars:

Gene Edited & Engineered Stem Cell-Oncolytic Virus Platform Drives Immunotherapy for Metastatic Cancers 3:45 pm

Gene editing and engineering techniques have been combined with stem cell and oncolytic virus technology to develop a powerful platform for immunotherapy in metastatic cancers The platform utilizes gene editing tools, such as CRISPR-Cas9, to modify stem cells and oncolytic viruses with specific anti-cancer properties Stem cells, with their ability to self-renew and differentiate into…Read more

day: Day Two